← FDA Drug Approvals (Drugs@FDA)

CLOBETASOL PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2018-04-17

Drug application

FDA Application #

ANDA209701

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOBETASOL PROPIONATE

Generic name

CLOBETASOL PROPIONATE

Active ingredients

CLOBETASOL PROPIONATE

Dosage form

OINTMENT

Route

TOPICAL

Marketing status

Prescription

Sponsor

XIROMED

Manufacturer

Xiromed, LLC

First approval

2018-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown